Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
ORA, Inc. clinical trials
The registry lists 26 studies whose lead sponsor is ORA, Inc.. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 16, 2025.
Keep track of what changes. Save the ORA, Inc. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesWhere
- United States
- 22
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to ORA, Inc..
- ORA, Inc.26 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 26 of 26.
- A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry EyeNot yet recruitingNCT07068958Phase 2
- Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease (DED)RecruitingNCT06178679Phase 3
- A Clinical Study Comparing the Comfort of Three Commercially Available Contact LensesWithdrawnNCT02298400Not applicable
- Visual Function Tests in Age-related Macular DegenerationTerminatedNCT03275753
- Efficacy Study of Ketorolac and HPMC to Treat Dry EyeWithdrawnNCT03693183Phase 2
- Safety and Efficacy of TOP1630 for Dry Eye SyndromeCompletedNCT03088605Phase 2
- Symptom Response in Normal and Dry Eye Patients Secondary to Application of a Menthol-Containing Eyedrop (Rohto® Hydra)CompletedNCT02985827Phase 4
- Mucin Levels in Dry Eye and Normal PopulationsCompletedNCT05911555
- Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic ConjunctivitisCompletedNCT03320434Phase 2
- An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to PlaceboCompletedNCT01439815Phase 4
- A Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft as Measured by In-Vivo Confocal MicroscopyCompletedNCT02308501Phase 4
- Efficacy and Safety of PL9643 Ophthalmic Solution in Subjects With Dry EyeCompletedNCT04268069Phase 2
- Safety and Efficacy Study of a Testosterone Eye Drop for the Treatment of Meibomian Gland DysfunctionCompletedNCT00755183Phase 2
- Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) ModelCompletedNCT00689078Phase 4
- Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge ModelCompletedNCT01730872Phase 4
- Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) ModelCompletedNCT01534195Phase 4
- Food Allergy Diagnostic Test Response to Previous Oral Challenge ResponseCompletedNCT03693456Not applicable
- Food Allergy Challenge Diagnostic StudyCompletedNCT02606721
- Flicker Fusion Thresholds Between Young and Old Subjects at Various Luminance LevelsCompletedNCT03079570
- Study Evaluating Nasal Symptoms Induced by a Nasal Allergen Challenge (NAC) To House Dust Mite AllergenCompletedNCT01936818
- Effect of Controlled Adverse Environment (CAE) on Tear Film StabilityCompletedNCT01547936
- An Allergen BioCube (ABC) Study Evaluating the Onset of Action of Fluticasone Furoate Nasal Spray and Olopatadine Nasal Spray Compared to PlaceboWithdrawnNCT01076439Phase 4
- A Single-Center Pilot Study to Assess Macular FunctionCompletedNCT01204541
- Conjunctival Allergen Challenge (CAC) Following Allergen Exposure in the Allergen BioCube (ABC)CompletedNCT00985296
- A Pilot Study Evaluating the Signs and Symptoms of Seasonal Allergic Rhinoconjunctivitis Following Exposure in the Allergen BioCubeCompletedNCT00985075
- A Single-Center Evaluation of the Pattern of Allergic Signs and Symptoms During 4 Weeks in Ragweed SeasonCompletedNCT00982163